Clinical Trial Update: Rectal NSAIDs With/Without PD Stent for PEP Prevention [NA]

View source ↗

Summary

A clinical trial evaluating rectal NSAIDs with or without a pancreatic duct stent to prevent post-ERCP pancreatitis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-ercp Pancreatitis

Drugs mentioned

• Rectal NSAIDs (Non-steroidal anti-inflammatory drugs)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Post-ERCP Acute Pancreatitis, Non-steroid Anti-inflammatory Drugs | NA | Status: RECRUITING